Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 8,142 | 7,737 | 10,177 | 11,008 | 13,048 |
| Operating Income | -8,142 | -7,737 | -10,177 | -11,008 | -13,048 |
| Interest Expense | 31 | 33 | 38 | 42 | -206 |
| Other Income | 759 | 646 | 829 | 873 | 610 |
| Pre-tax Income | -7,414 | -7,124 | -9,386 | -10,177 | -12,232 |
| Net Income Continuous | -7,414 | -7,124 | -9,386 | -10,177 | -12,232 |
| Net Income | $-7,414 | $-7,124 | $-9,386 | $-10,177 | $-12,232 |
| EPS Basic Total Ops | -6.00 | -5.60 | -6.20 | -6.60 | -8.00 |
| EPS Basic Continuous Ops | -6.07 | -5.58 | -6.15 | -6.59 | -7.96 |
| EPS Diluted Total Ops | -6.00 | -5.60 | -6.20 | -6.60 | -8.00 |
| EPS Diluted Continuous Ops | -6.07 | -5.58 | -6.15 | -6.59 | -7.96 |
| EBITDA(a) | $-7,813 | $-7,405 | $-9,497 | $-10,998 | $-12,697 |